NCT03359239 2023-05-16Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial CancerIcahn School of Medicine at Mount SinaiPhase 1 Completed10 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled